- Home
- LGCL vs MDCX Comparison
LGCL vs MDCX Comparison
Compare LGCL & MDCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGCL
- MDCX
- Stock Information
- Founded
- LGCL 2009
- MDCX 2008
- Country
- LGCL China
- MDCX Canada
- Employees
- LGCL N/A
- MDCX N/A
- Industry
- LGCL
- MDCX
- Sector
- LGCL
- MDCX
- Exchange
- LGCL NYSE
- MDCX Nasdaq
- Market Cap
- LGCL 47.7M
- MDCX 44.0M
- IPO Year
- LGCL 2024
- MDCX N/A
- Fundamental
- Price
- LGCL $1.07
- MDCX $2.52
- Analyst Decision
- LGCL
- MDCX Strong Buy
- Analyst Count
- LGCL 0
- MDCX 2
- Target Price
- LGCL N/A
- MDCX $23.50
- AVG Volume (30 Days)
- LGCL 277.5K
- MDCX 423.8K
- Earning Date
- LGCL 01-01-0001
- MDCX 05-12-2025
- Dividend Yield
- LGCL N/A
- MDCX N/A
- EPS Growth
- LGCL N/A
- MDCX N/A
- EPS
- LGCL 0.07
- MDCX N/A
- Revenue
- LGCL $145,690,427.00
- MDCX N/A
- Revenue This Year
- LGCL N/A
- MDCX N/A
- Revenue Next Year
- LGCL N/A
- MDCX N/A
- P/E Ratio
- LGCL $9.92
- MDCX N/A
- Revenue Growth
- LGCL N/A
- MDCX N/A
- 52 Week Low
- LGCL $0.28
- MDCX $1.80
- 52 Week High
- LGCL $3.31
- MDCX $8.94
- Technical
- Relative Strength Index (RSI)
- LGCL N/A
- MDCX N/A
- Support Level
- LGCL N/A
- MDCX N/A
- Resistance Level
- LGCL N/A
- MDCX N/A
- Average True Range (ATR)
- LGCL 0.00
- MDCX 0.00
- MACD
- LGCL 0.00
- MDCX 0.00
- Stochastic Oscillator
- LGCL 0.00
- MDCX 0.00
About LGCL LUCAS GC LIMITED
Lucas GC Ltd is a technology-driven online agent-centric human capital management service provider targeting professionals based on PaaS in China. Its business segments consist of recruitment services, outsourcing services, and other services, which include information technology services and training services.
About MDCX Medicus Pharma Ltd. Common Stock
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.